medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2009, Número 1

<< Anterior Siguiente >>

Rev Invest Clin 2009; 61 (1)


Estenosis carotídea aterosclerosa. ¿Cómo decidir endartectomía versus colocación de Stent, versus sólo tratamiento médico?

Cantú-Brito C

Idioma: Español
Referencias bibliográficas: 61
Paginas: 53-65
Archivo PDF: 336.26 Kb.


FRAGMENTO

Mujer de 64 años de edad, diestra, con historia familiar de hipertensión arterial sistémica (HAS) y diabetes mellitus. Portadora de HAS de 10 años de evolución tratada con enalapril 10 mg/día y felodipino 5 mg/día. Se conoce diabética de 10 años de evolución con control regular a base de glibenclamida y metformina. Inicia su padecimiento dos días antes de su admisión al hospital por haber presentado en forma súbita pérdida del estado de alerta y caída desde su propia altura.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Fisher CM. Occlusion of the internal carotid artery. Arch Neurol Psychiatry 1951; 65: 346-77.

  2. Eastcott HG, Pickering GW, Rob C. Reconstruction of the internal carotid artery in a patient with intermittent attacks of hemiplegia. Lancet 1954; 2: 994-6.

  3. Mead GE, Shingler H, Farrell A, O’Neill PA, McCollum CN. Carotid disease in acute stroke. Age Ageing 1998; 27: 677-82.

  4. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19: 1083-92.

  5. Naghavi M, Libby P, Falk E, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part I. Circulation 2003; 108: 1664-72.

  6. Fisher M, Paganini-Hill A, Martin A, et al. Carotid plaque pathology: thrombosis, ulceration, and stroke pathogenesis. Stroke 2005; 36: 253-7.

  7. Spagnoli LG, Mauriello A, Sangiorgi G, et al. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 2004; 292: 1845-52.

  8. Gillard JH. Advances in atheroma imaging in the carotid. Cerebrovasc Dis 2007; 24(Suppl. 1): 40-8.

  9. Nicolaides AN, Kakkos SK, Griffin M, et al. Effect of image normalization on carotid plaque classification and the risk of ipsilateral hemispheric ischemic events: results from the Asymptomatic Carotid Stenosis and Risk of Stroke study. Vascular 2005; 13: 211-21.

  10. Cai J, Hatsukami TS, Ferguson MS, et al. In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology. Circulation 2005; 112: 3437-44.

  11. Takaya N, Yuan C, Chu B, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI – initial results. Stroke 2006; 37: 818-23.

  12. Rothwell PM, Eliasziw M, Gutnikov SA, Fox AJ, Taylor DW, Mayberg MR, et al. Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003; 361: 107-16.

  13. Ferguson GG, Eliasziw M, Barr HWK, et al. The North American Symptomatic Carotid Endarterectomy Trial. Surgical Results in 1415 Patients. Stroke 1999; 30: 1751-8.

  14. Hennerici M, Hulsbomer HB, Lamerts D, Rautenberg W. Natural history of asymptomatic extracranial arterial disease. Brain 1987; 110: 777-91.

  15. Norris JW, Zhu CZ, Bornstein NM, Chambers BR. Vascular risks of asymptomatic carotid stenosis. Stroke 1991; 22: 1485-90.

  16. Dennis M, Bamford J, Sandercock P, et al. Prognosis of Transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 1990; 21: 848-53.

  17. Barnett HJM, Meldrum E, Hand PJ, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Carotid Endarterectomy. A Neurotherapeutic Advance. Arch Neurol 2000; 57: 40-45.

  18. Bos MJ, van Rijn ME, Witteman JCM. Incidence and Prognosis of Transient Neurological Attacks. JAMA 2007; 298(24): 2877-85.

  19. Hand HP, Kwan J, Lindley RI, Dennis MS, Wardlaw JM. Distinguishing Between Stroke and Mimic at the Bedside. The Brain Attack Study. Stroke 2006; 37: 769-75.

  20. European Carotid Surgery Triallists’. MRC Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%), or mild (0-29%) carotid stenosis. Lancet 1991; 337: 1235-43.

  21. European Carotid Surgery Triallists’ Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final result of the MRC European Carotid Surgery Trial. Lancet 1998; 351: 1379-87.

  22. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high grade carotid stenosis. N Engl J Med 1991; 325: 445-53.

  23. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med 1998; 339: 1415-25.

  24. Fox AJ. How to measure carotid stenosis. Radiology 1993; 186: 316-18.

  25. Goldestein. Extracranial carotid artery stenosis. Emerging strategies. Stroke 2003; 34: 2767-73.

  26. Rothwell PM, Eliasiw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-24.

  27. Alamowitch S, Eliasiw M, Algra S, et al. Risks, causes and prevention of ischaemic stroke in elderly patients with symptomatic internal carotid artery stenosis. Lancet 2001; 357: 1154-160.

  28. Eliasziw M, Streifler JY, Fox AJ, et al. Significance of plaque ulceration in symptomatic patients with high grade carotid stenosis. Stroke 1994; 25: 304-8.

  29. Rothwell PM, Gibson R, Warlow CP. Interrelation between plaque surface morphology and degree of stenosis on carotid angiograms and risk of ischemic stroke in patients with symptomatic carotid stenosis. European Carotid triasllist’s Collaborative Group. Stroke 2000; 31: 615-21.

  30. Rothwell PM, Slattery J, Warlow CP. Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ 1997; 315: 1571-7.

  31. Kapelle LJ, Eliasiw M, Fox AJ, et al. Importance of intracranial atherosclerotic disease in patients with symptomatic stenosis of the internal carotid artery. Stroke 1999; 30: 282-6.

  32. Henderson RD, Eliasziw M, Fos AJ, Rothwell PM, Barnett HJ. Angiographically Defined Collateral Circulation and Risk of Stroke in Patients With Severe Carotid Artery Stenosis. Stroke 2000; 31; 128-32.

  33. Rothwell PM, Warlow CP. Low risk of ischemic stroke in patients with reduced internal carotid artery lumen diameter distal to severe symptomatic carotid stenosis: cerebral protection due to low postestenotic flow? European Carotid Triallists´Collaborative Group. Stroke 2000; 31: 622-30.

  34. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow ChP. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet 2005; 365: 256-65.

  35. Rothwell PM, Warlow CP. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists’ Collaborative Group. Lancet 1999; 353: 2105-10.

  36. Meschia JF, Brott GT, Hobson RW. Diagnosis and invasive management of carotid atherosclerosis stenosis. Mayo Clin Proc 2007; 82: 851-8.

  37. Atkins MD, Bush RL. Embolic protection devices for carotid artery stenting: have they made a significant difference in outcomes? Semin Vasc Surg 2007; 20: 244-51.

  38. Yadav JS, Wholey MH, Kuntz RE, Schmitt E. Protected carotidartery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.

  39. Ringleb PA, Allenberg J, Bruckmann H, Branchereau A, Moulin T, Becquemin JP. 30 day results from the SPACE trial of stent protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 68: 1239-47.

  40. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355:1660-71.

  41. Mas JL, Chatellier G. Recent carotid stenting trials. Lancet Neurol 2007; 6: 295-6.

  42. Stingele R, Berger J, Alfk e K, et al, for the SPACE investigators. Clinical and angiographic risk factors for stroke and death within 30 days after carotid endarterectomy and stent-protected angioplasty: a subanalysis of the SPACE study. Lancet Neurol 2008; 7: 716-22.

  43. Hobson RW, Howard VJ, Roubin GS, et al. Carotid artery stenting is ssociated with increased complications in octogenarians: 30-day stroke and death rates in the CREST lead-in phase. J Vasc Surg 2004; 40: 1106-11.

  44. Leys D. Profiling of patients and risk after carotid stenting. Lancet Neurol 2008: 193-4.

  45. O’Leary DH, Polak JF, Kronmal RA, et al. Distribution and correlates of sonographically detected carotid artery disease in the cardiovascular health study: the CHS collaborative research group. Stroke 1992; 23: 1752-60.

  46. Hennerici M, Aulich A, Sandmann W, Freund HJ. Incidence of asymptomatic extracranial arterial disease. Stroke 1981; 12: 750-8.

  47. Meissner I, Wiebers DO, Whisnant JP, O’Fallon WM. The natural history of asymptomatic carotid artery occlusive lesions. JAMA 1987; 258: 2704-7.

  48. Bogousslavsky J, Despland PA, Regli F. Asymptomatic tight stenosis of the internal carotid artery: long-term prognosis. Neurology 1986; 36: 861-3.

  49. Hennerici M, Hulsbomer HB, Hefter H, et al. Natural history of asymptomatic extracranial arterial disease: results of a longterm prospective study. Brain 1987; 110(3): 777-91.

  50. Goessens BMB, Visseren FLJ, Kappelle LJ, et al. Asymptomatic carotid artery stenosis and the risk of new vascular events in patients with manifest arterial disease. The SMART Study. Stroke 2007; 38: 1470-5.

  51. Redgrave JN, Rothwell PM. Asymptomatic carotid stenosis: what to do. Curr Opin Neurol 2007; 20: 58-64.

  52. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995: 273: 1421-8.

  53. Halliday A, Mansfield A, Marro J, et al. prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet 2004; 363: 1491-502.

  54. Rothwell PM, Goldstein LB. Carotid endarterectomy for asymptomatic carotid stenosis. Asymptomatic Carotid Surgery Trial. Stroke 2004; 35: 2425-7.

  55. Markus HS, MacKinnon A. Asymptomatic embolization detected by Doppler ultrasound predicts stroke risk in symptomatic carotid artery stenosis. Stroke 2005; 36: 971-5.

  56. Spence JD, Tamayo A, Lownie SP, et al. Absence of microemboli on transcranial Doppler identifies low-risk patients with asymptomatic carotid stenosis. Stroke 2005; 36: 2373-8.

  57. Silvestrini M, Vernieri F, Pasqualetti P, Matteis M, Passarelli F. Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis. JAMA 2000; 283: 2122-7.

  58. Derdeyn CP. Carotid stenting for asymptomatic carotid stenosis: trial it. Stroke 2007; 38: 715-20.

  59. Fayad P. Endarterectomy and stenting for asymptomatic carotid stenosis: a race at breakneck speed. Stroke 2007; 38: 707-14.

  60. Rerkasem K, Shearman CP, Williams JA, et al. C-reactive protein is elevated in symptomatic compared with asymptomatic patients with carotid artery disease. Eur J Vasc Endovascular Surg 2002; 23: 505-9.

  61. Debing E, Peeters E, Demanet C, et al. Markers of inflammation in patients with symptomatic and asymptomatic carotid artery stenosis: a case-control study. Vasc Endovascular Surg 2008; 42: 122-7.




2020     |     www.medigraphic.com